Market Tracker

10/21 6:05pm ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.7119
Data as of Oct 21
 -0.0032 / -0.45%
Today’s Change
0.65
Today|||52-Week Range
4.00
-23.04%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.72
Today’s open0.70
Day’s range0.70 - 0.72
Volume156,395
Average volume (3 months)326,305
Market cap$43.4M
Dividend yield--
Data as of 3:59pm ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)+54.29%
Earnings growth (this year)-34.37%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.55

Competitors

 Today’s
change
Today’s
% change
--Protea Biosciences G...-0.03-4.41%
PBMDPrima BioMed Ltd-0.00-0.01%
BCLIBrainstorm Cell Ther...+0.09+2.49%
CASICASI Pharmaceuticals...-0.02-1.27%
Data as of 3:59pm ET, 10/21/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts